John Overdeck’s Abeona Therapeutics ABEO Stock Holding History

John Overdeck’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$499K	Buy	+80,737	New	+$443K	﹤0.01%	4162
2024 Q1	–	Sell	-56,948	Closed	-$285K	–	2989
2023 Q4	$285K	Buy	+56,948	New	+$251K	﹤0.01%	2712
2020 Q3	–	Sell	-3,506	Closed	-$255K	–	3017
2020 Q2	$255K	Buy	3,506 +3,051	+671%	+$211K	﹤0.01%	2483
2020 Q1	$24K	Buy	+455	New	+$30.4K	﹤0.01%	2966
2019 Q4	–	Sell	-5,196	Closed	-$294K	–	3597
2019 Q3	$294K	Sell	5,196 -67	-1%	-$5.02K	﹤0.01%	2978
2019 Q2	$629K	Buy	+5,263	New	+$882K	﹤0.01%	2320

Other funds holding ABEO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OIA

OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

John Overdeck's ABEO Position: Q2 2026 in Review

John Overdeck opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 80,737 shares worth $499K. The stake represents ﹤0.01% of the portfolio and ranks #4162 among its holdings. This is a return to the name: John Overdeck previously reported a position in ABEO as recently as Q4 2023.

John Overdeck first reported a position in ABEO in Q2 2019 and has held it in 6 quarters since. The position peaked at $629K in Q2 2019. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

John Overdeck held 80,737 shares of Abeona Therapeutics worth $499K as of Q2 2026.
Abeona Therapeutics was a new John Overdeck position in Q2 2026.
Abeona Therapeutics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4162 holding.
John Overdeck first reported a position in Abeona Therapeutics in Q2 2019 and has held it in 6 quarters since.
John Overdeck's Abeona Therapeutics position peaked at $629K in Q2 2019.
126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.